The present meta‐analysis indicated a significant association between curcumin supplementation and a decrease in ALT and AST levels in patients with nonalcoholic fatty liver disease (NAFLD). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.